YD Bio Limited (YDES)
NASDAQ: YDES · Real-Time Price · USD
7.90
-0.25 (-3.07%)
Mar 9, 2026, 4:00 PM EDT - Market closed
YD Bio Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 |
| Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Market Capitalization | 556 | 45 | 47 | 50 |
| Market Cap Growth | 1123.10% | -4.31% | -5.87% | - |
| Enterprise Value | 552 | 43 | - | - |
| Last Close Price | 7.90 | 11.25 | 11.03 | 10.43 |
| PE Ratio | - | - | 3497.13 | - |
| PS Ratio | 1088.50 | 88.92 | 135.44 | 138.36 |
| PB Ratio | 1.73 | 6.89 | 2062.32 | 5396.83 |
| P/TBV Ratio | 142.07 | 11.61 | 2062.32 | 5396.83 |
| P/FCF Ratio | - | - | - | 720.26 |
| P/OCF Ratio | - | - | - | 720.26 |
| EV/Sales Ratio | 1082.41 | 83.59 | - | - |
| Debt / Equity Ratio | 0.00 | 0.00 | 2.07 | 13.30 |
| Debt / EBITDA Ratio | - | - | 1.18 | 6.81 |
| Debt / FCF Ratio | - | - | - | 1.77 |
| Net Debt / Equity Ratio | -0.47 | -0.47 | -1.72 | 10.07 |
| Net Debt / EBITDA Ratio | 2.29 | 2.29 | 5.34 | -2.28 |
| Net Debt / FCF Ratio | 1.63 | 1.63 | 0.71 | 1.34 |
| Asset Turnover | 0.14 | 0.14 | 1.28 | - |
| Inventory Turnover | 6.65 | 6.65 | 3.64 | - |
| Quick Ratio | 12.91 | 12.91 | 0.62 | 0.40 |
| Current Ratio | 13.18 | 13.18 | 0.91 | 0.75 |
| Return on Equity (ROE) | -42.69% | -42.69% | 83.89% | - |
| Return on Assets (ROA) | -25.43% | -25.43% | -2.25% | - |
| Return on Invested Capital (ROIC) | -42.01% | -84.41% | -17.44% | -43.47% |
| Return on Capital Employed (ROCE) | -22.10% | -22.10% | -42.80% | -79.40% |
| Earnings Yield | -0.25% | -3.11% | 0.03% | -0.10% |
| FCF Yield | -0.34% | -4.21% | -0.12% | 0.14% |
| Buyback Yield / Dilution | -4.01% | -4.01% | - | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.